Anuh Pharma board meeting on May 20, 2026, to approve FY26 audited results and potential dividend.
Agenda includes re-appointment of two directors and approval of statutory and secretarial audit reports.
Trading window closed from April 1, 2026, until May 22, 2026, for declaration of results.